| Title | Date | PubMed ID |
|---|
| Time-resolved analysis of the matrix metalloproteinase 10 substrate degradome. | 2014 Feb | 24281761 |
| Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes. | 2013 | 24073280 |
| Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma. | 2012 Sep-Oct | 22121946 |
| Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure. | 2012 May 4 | 22427646 |
| Matrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential. | 2012 | 22545096 |
| Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism. | 2011 Dec 20 | 22104553 |
| Regulation of MMP10 expression by the transcription factor CHF1/Hey2 is mediated by multiple E boxes. | 2011 Dec 2 | 22079635 |
| Matrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formation. | 2011 | 22022614 |
| MMP-10/stromelysin-2 promotes invasion of head and neck cancer. | 2011 | 21998657 |
| Age- and gender-dependent changes in connective tissue remodeling: physiological differences in circulating MMP-3, MMP-10, TIMP-1 and TIMP-2 level. | 2011 | 20215736 |